Application 220016
- Type
- ANDA
- Sponsor
- KLM LABS PVT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MESALAMINE | MESALAMINE | ENEMA;RECTAL | 4GM/60ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220016-001 | MESALAMINE | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220016-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | MESALAMINE | 4GM/60ML | ENEMA / RECTAL | AB | 2026-03-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220016-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220016-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220016-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220016-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 4e3b6325-a5bf-4c47-931c-142c0e4d7c3a | 2025-01-09 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | AvPAK | f2657911-6f06-71fb-e053-2a95a90ae6f7 | 2025-01-09 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Zydus Lifesciences Limited | aa63b4bb-2de7-40aa-b26b-1b00b0183eac | 2025-01-09 | Mesalamine MESALAMINE | |
| Mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | f458d574-7b5b-44f1-86be-8b18880dc67f | 2025-01-08 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| mesalamine | MESALAMINE | Zydus Lifesciences Limited | 29c0dd58-d2cf-40fa-bc32-0eab61937331 | 2024-11-30 | mesalamine MESALAMINE | |
| mesalamine | MESALAMINE | Zydus Lifesciences Limited | 52d96501-47f3-45d8-a181-98763b9f8965 | 2024-11-30 | mesalamine MESALAMINE | |
| Mesalamine | MESALAMINE | Zydus Lifesciences Limited | 04073681-a834-4f45-91c5-224b608b30e6 | 2024-11-30 | Mesalamine MESALAMINE | |
| Mesalamine | MESALAMINE | American Health Packaging | 77140634-9f32-40ca-8c83-9fcc3e373c16 | 2024-11-22 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | NorthStar RxLLC | 8233f158-9da5-4fd2-b2c3-9db89448371f | 2024-11-21 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | American Health Packaging | a74ab9f4-ffcd-4bbf-88a5-342e6a38aabb | 2024-11-21 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | 1e561474-6169-410e-b83d-7e96d375831d | 2024-11-07 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | 9756d07b-2939-460f-94d3-e338c28cb993 | 2024-11-07 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | b48df65a-a717-479e-9122-8b0f1406c841 | 2024-11-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Sun Pharmaceutical Industries Inc. | c2f84490-70b8-4998-907d-a77e9f791de1 | 2024-08-27 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | baa76dde-3c5b-4ff4-ba0c-f19660a796c1 | 2024-08-14 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | b2a5b110-7537-4ffc-bf0a-f0fe13379c9d | 2024-08-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | d50f2c37-5675-49f3-bdd4-3b16d333ed40 | 2024-08-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | a4ddf68d-1502-4242-89aa-c96436bdcbf6 | 2024-08-01 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | 06792d20-d7e9-4b66-a4cb-cd0cf1a2db25 | 2024-06-28 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
| Mesalamine | MESALAMINE | Rising Pharma Holdings, Inc. | de981df1-747a-480d-a866-e72332a1544d | 2024-06-14 | Warnings, Adverse reactions | Mesalamine MESALAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.